Lamivudine-Induced Recurrent Drug Eruption in HIV: A Curious Case of Its Treatment
Lists
Only you see this
Abstract
Abstract Background: Drug eruption may occur when HIV patients receive antiviral treatment. However, Lamivudine-induced repeated drug eruption has rarely been reported among the antiretrovirals. Case presentation: We report a rare case of repeated drug eruption caused by Lamivudine. The treatment history of this patient was interesting. Patients developed repeated drug eruption regardless of treatment TDF+3TC+EFV or TDF+3TC+LPV/r. The viral load of the patient in 2016 and 2017 was 58 copies/ml and < 50 copies/ml respectively by TDF+LPV/r with no drug eruption, but antiviral failure was found in 2018. This patient was successfully treated with TDF+LPV/r+DTG in 2019 and 2020. Conclusions: Through repeated drug eruption of the patient, we found that the allergenic drug is Lamivudine. The viral load of the patient can be effectively controlled by TDF+LPV/r+DTG.
BibTeX
@inproceedings{wang2021lamivudine,
author = {Hong Wang and Hongbo Li and Jian'e Sui and Juan Zhao and Saisai Ma and Peng Chen and Guangyong Xu},
title = {{Lamivudine-Induced Recurrent Drug Eruption in HIV: A Curious Case of Its Treatment}},
booktitle = {Research},
year = {2021},
doi = {10.21203/rs.3.rs-167709/v1},
}Loading related content...